Prospective Clinical Trial
Official title:
STEISURE - Trident II - A Registerbased Multicentric Prospective Study
In a prospective register-based study, we aim to evaluate the implant survival, clinical outcomes and X-ray findings by following a cohort of patients operated with the Trident II cup.
Data will be collected from a cohort consisting of minimum 500 total hip arthroplasties. The patients will be recruited from multiple high volume centers in Sweden. To determine if there is evidence of inferiority as per benchmarking recommendations by The Orthopaedic Data Evaluation Panel the following parameters will be studied: Clinical parameters such as EQ-5D, Oxford Hip Score and Forgotten Joint Score, preoperative and after 1, 3, 6 and 10 years. Conventional radiography will be done preoperatively, postoperatively, 3, 6 and 10 years after total hip replacement. CTMA will be done postoperatively, 3 and 6 month and 2 years after total hip replacement. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01694108 -
Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.
|
Phase 4 | |
| Completed |
NCT00520416 -
Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair
|
N/A | |
| Recruiting |
NCT05145712 -
Quantitative Bowel Readiness Assessment System in Predicting the Missed Detection Rate of Adenomas
|
N/A | |
| Recruiting |
NCT03728829 -
Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
|